| Polymorphs, salts, and cocrystals: what’s in a name? S Aitipamula, R Banerjee, AK Bansal, K Biradha, ML Cheney, ... Crystal growth & design 12 (5), 2147-2152, 2012 | 1158 | 2012 |
| The role of cocrystals in pharmaceutical science N Shan, MJ Zaworotko Drug discovery today 13 (9-10), 440-446, 2008 | 964 | 2008 |
| Mechanochemistry and co-crystal formation: effect of solvent on reaction kinetics N Shan, F Toda, W Jones Chemical Communications, 2372-2373, 2002 | 441 | 2002 |
| Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics ML Cheney, DR Weyna, N Shan, M Hanna, L Wojtas, MJ Zaworotko Journal of pharmaceutical sciences 100 (6), 2172-2181, 2011 | 292 | 2011 |
| Effects of crystal form on solubility and pharmacokinetics: a crystal engineering case study of lamotrigine ML Cheney, N Shan, ER Healey, M Hanna, L Wojtas, MJ Zaworotko, ... Crystal Growth & Design 10 (1), 394-405, 2010 | 286 | 2010 |
| Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation RJ Mead, N Shan, HJ Reiser, F Marshall, PJ Shaw Nature Reviews Drug Discovery 22 (3), 185-212, 2023 | 278 | 2023 |
| Crystal engineering using 4, 4′-bipyridyl with di-and tricarboxylic acids N Shan, AD Bond, W Jones Crystal engineering 5 (1), 9-24, 2002 | 174 | 2002 |
| Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics N Shan, ML Perry, DR Weyna, MJ Zaworotko Expert opinion on drug metabolism & toxicology 10 (9), 1255-1271, 2014 | 152 | 2014 |
| Supramolecular architectures of meloxicam carboxylic acid cocrystals, a crystal engineering case study ML Cheney, DR Weyna, N Shan, M Hanna, L Wojtas, MJ Zaworotko Crystal growth & design 10 (10), 4401-4413, 2010 | 151 | 2010 |
| Improving solubility and pharmacokinetics of meloxicam via multiple-component crystal formation DR Weyna, ML Cheney, N Shan, M Hanna, MJ Zaworotko, V Sava, ... Molecular pharmaceutics 9 (7), 2094-2102, 2012 | 149 | 2012 |
| Selective polymorph transformation via solvent-drop grinding AV Trask, N Shan, WDS Motherwell, W Jones, S Feng, RBH Tan, ... Chemical communications, 880-882, 2005 | 147 | 2005 |
| An assessment of lattice energy minimization for the prediction of molecular organic crystal structures GM Day, J Chisholm, N Shan, WDS Motherwell, W Jones Crystal growth & design 4 (6), 1327-1340, 2004 | 132 | 2004 |
| Crystallization method and bioavailability M Hanna, N Shan, M Cheney, D Weyna, RK Houck US Patent 8,399,023, 2013 | 117 | 2013 |
| Oral forms of a phosphonic acid derivative M Hanna, N Shan, M Cheney, D Weyna US Patent 8,980,868, 2015 | 109 | 2015 |
| In vivo studies of crystalline forms of meloxicam M Hanna, N Shan, ML Cheney, DR Weyna US Patent 8,124,603, 2012 | 99 | 2012 |
| Identification of supramolecular templates: design of solid-state photoreactivity using structural similarity N Shan, W Jones Tetrahedron letters 44 (18), 3687-3689, 2003 | 97 | 2003 |
| Crystallization method and bioavailability M Hanna, N Shan, ML Cheney, DR Weyna, RK Houck US Patent 8,933,057, 2015 | 89 | 2015 |
| Crystallization method and bioavailability M Hanna, N Shan, ML Cheney, DR Weyna, R Houck US Patent 9,169,279, 2015 | 84 | 2015 |
| Co-crystal structures of 4, 7-phenanthroline and carboxylic acids: synthon competition and prediction N Shan, E Batchelor, W Jones Tetrahedron letters 43 (48), 8721-8725, 2002 | 70 | 2002 |
| Poly (tetrahydrobenzodithiophene): High discharge specific capacity as cathode material for lithium batteries L Zhan, Z Song, N Shan, J Zhang, J Tang, H Zhan, Y Zhou, Z Li, C Zhan Journal of Power Sources 193 (2), 859-863, 2009 | 66 | 2009 |
